Cognitive function and the costs of Alzheimer disease. An exploratory study.
about
Economic considerations in the management of Alzheimer's diseaseDeterminants of costs of care for patients with Alzheimer's diseaseCognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacyIntelligent assistive technology applications to dementia care: current capabilities, limitations, and future challengesDevelopment of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.WHEDA study: effectiveness of occupational therapy at home for older people with dementia and their caregivers--the design of a pragmatic randomised controlled trial evaluating a Dutch programme in seven German centres.An economic perspective on Alzheimer's disease.A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada.Acetylcholinesterase inhibitors in Alzheimer's disease.Dementia in rural primary care practices in Lake County, Oregon.Study protocol of the multi-site randomised controlled REDALI-DEM trial--the effects of structured relearning methods on daily living task performance of persons with dementia.Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.Relation between severity of Alzheimer's disease and costs of caringReality orientation therapy to delay outcomes of progression in patients with dementia. A retrospective study.CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative studyPharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease.Integrating care for older adults with cognitive impairmentSleep and cognition in people with Alzheimer's disease.Altered Frontal Lateralization Underlies the Category Fluency Deficits in Older Adults with Mild Cognitive Impairment: A Near-Infrared Spectroscopy StudyPresent and prospective clinical therapeutic regimens for Alzheimer's disease.Mild physical impairment predicts future diagnosis of dementia of the Alzheimer's type.The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease.A review of the methods used to estimate the cost of Alzheimer's disease in the United States.Assessment of behavioral and psychological symptoms of dementia.Predicting 10-year care requirements for older people with suspected Alzheimer's disease.The economic consequences of Alzheimer's disease in the context of new drug developments.Road to the nursing home: costs and disease progression among medicare beneficiaries with ADRD.How much does it really cost to care for persons with Alzheimer's disease?Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns.Reduced frontal activation during a working memory task in mild cognitive impairment: a non-invasive near-infrared spectroscopy study.Homocysteine as a predictor of cognitive decline in Alzheimer's disease.The economic cost of Alzheimer's disease: Family or public health burden?The impact of symptom severity on the cost of Alzheimer's disease.Adenosine A(1) receptors using 8-dicyclopropylmethyl-1-[(11)C]methyl-3-propylxanthine PET in Alzheimer's disease.Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.Which Alzheimer patients are at risk for rapid cognitive decline?Neuroprotective actions of 2,4-dinitrophenol: Friend or foe?Patients with Alzheimer's disease living at home in France: costs and consequences of the disease.Evaluation of an integrated primary care-led dementia shared care program in Singapore: An effectiveness and cost-effectiveness study.Comparing three methods of computerised cognitive training for older adults with subclinical cognitive decline.
P2860
Q22241448-FDFE5099-F787-41C1-82ED-402E05373DAAQ22252908-109751A0-1CC9-49FC-AF23-A9A231AE5A11Q27022204-70357366-D711-4C43-A6F8-DDD947FF2AB2Q30438132-86FAEA8E-588E-4357-A7FF-2213099007AAQ30845414-6F31F0E5-9615-464A-BC9F-7677CAFB6D1DQ30874792-32F86B3C-5773-4196-BB90-36F642839BBAQ33711096-89FEF349-E695-4200-8252-B01DFBF45A66Q33751490-513F8EAF-C58C-4AD4-8CAC-076A081BEC5FQ33785568-796B4AB9-03A2-45D1-8DB1-E76E8757124BQ33982590-040A36D7-10C5-4C09-9F74-D960B356C5D3Q33996068-612C91F6-21C5-4898-A268-2F0C05EB9B01Q34007177-5C0D84CD-B0DF-47BC-856B-32F778B060BCQ34029549-00ADE7A4-F25C-44DA-9EE4-4D92190EB200Q34397422-ECC33DC9-9B69-4631-9191-A8327137CBB1Q34787474-4739A4EF-1332-4472-A190-84A65C49C0A9Q35226216-F58E5295-75B5-401D-A45C-1E6E66B01357Q35870021-97EDEC71-57F1-4259-828B-D965D50AAD6DQ36242680-075E1CE9-8FA6-455A-8472-7BD8D2186D75Q36734791-2FDA61F2-BA13-4299-9B35-4F10AD191DDAQ36876447-0F2B2EB9-EA4D-4C97-AFDC-879EE9098B5CQ37257381-5A40B6C3-384B-4226-BD3E-F97DE83E2A98Q37798794-A4A71594-517B-468C-8F01-05F3710A45B1Q37874387-C666BB4A-580E-401C-95DC-40F38C5C3AA1Q40565440-1ED5B10B-2055-4252-9859-728D907AB190Q40760758-A5718AFD-00B4-4C95-B00B-CF6BBA0FF7DCQ40843678-13EFEF44-A769-4CCF-BCCC-C34568DCBB2BQ44159594-55E58E5C-7BA8-48C6-AEA6-78ABFC24B9A2Q44196720-8D64E840-96CA-4E94-A0CA-33FB680DC5EAQ44232146-F5462B5B-2DDD-48C8-A550-1E084FED5D93Q44896850-38852B91-1618-4496-87A0-8A06892C5741Q45988469-A7E4C553-6014-4C5F-A820-46C34F4DBC97Q46005653-B8879003-3C92-4B65-93DD-C217665B823AQ46128016-D294E95A-2469-4EEF-989A-CAC7428C2929Q46163996-EA4CA248-F215-4E1E-8912-984F2BEE8897Q46221396-3901433A-FB46-4895-B0B2-EC7098136DF3Q46823711-B8660F0F-B7BE-4408-9D44-27480BD7DE45Q47131459-339146C8-6426-4278-BFAF-0E46C99E5641Q47634099-3AA2E176-9B43-4472-A23A-CC1804ADA883Q48199921-FA158653-F02C-4D3A-AC06-FC6612DFF913Q50544284-0E96C5CF-319F-4095-A07E-086D395966DE
P2860
Cognitive function and the costs of Alzheimer disease. An exploratory study.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Cognitive function and the costs of Alzheimer disease. An exploratory study.
@en
Cognitive function and the costs of Alzheimer disease. An exploratory study.
@nl
type
label
Cognitive function and the costs of Alzheimer disease. An exploratory study.
@en
Cognitive function and the costs of Alzheimer disease. An exploratory study.
@nl
prefLabel
Cognitive function and the costs of Alzheimer disease. An exploratory study.
@en
Cognitive function and the costs of Alzheimer disease. An exploratory study.
@nl
P2093
P1433
P1476
Cognitive function and the costs of Alzheimer disease. An exploratory study.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1997.00550180013006
P577
1997-06-01T00:00:00Z